FDA Brief

Company record

Sambrosa Care Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Sambrosa Care Inc..

Warning letters

  1. Sambrosa Care Inc.

    FDA warns Sambrosa Care that its OTC sweet dreams Night Syrup is an unapproved, misbranded drug with excessive doxylamine dosing.

    High risk